Following the study strategy used in this research, the real detection rate in the cohort increased from 5.3% to at least 12.2% (2.3-fold increase; p < 0.001); it was also possible to reclassify four patients with no FH mutation who had been clinically diagnosed with FH before the present study (Figure 3). Here, FH is linked to familial hyperaldosteronism.